DK171392B1 - Anvendelse af N-(2-hydroxyethyl)nicotinamidnitrat eller et farmaceutisk acceptabelt salt deraf til fremstilling af et farmaceutisk præparat til forøgelse af hjernens glucoseoptagelse - Google Patents
Anvendelse af N-(2-hydroxyethyl)nicotinamidnitrat eller et farmaceutisk acceptabelt salt deraf til fremstilling af et farmaceutisk præparat til forøgelse af hjernens glucoseoptagelse Download PDFInfo
- Publication number
- DK171392B1 DK171392B1 DK441987A DK441987A DK171392B1 DK 171392 B1 DK171392 B1 DK 171392B1 DK 441987 A DK441987 A DK 441987A DK 441987 A DK441987 A DK 441987A DK 171392 B1 DK171392 B1 DK 171392B1
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxyethyl
- brain
- cerebral
- nitrate
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19879686 | 1986-08-27 | ||
| JP19879686 | 1986-08-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK441987D0 DK441987D0 (da) | 1987-08-25 |
| DK441987A DK441987A (da) | 1988-02-28 |
| DK171392B1 true DK171392B1 (da) | 1996-10-14 |
Family
ID=16397046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK441987A DK171392B1 (da) | 1986-08-27 | 1987-08-25 | Anvendelse af N-(2-hydroxyethyl)nicotinamidnitrat eller et farmaceutisk acceptabelt salt deraf til fremstilling af et farmaceutisk præparat til forøgelse af hjernens glucoseoptagelse |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4870090A (es) |
| JP (1) | JPH07121863B2 (es) |
| KR (1) | KR950002151B1 (es) |
| AU (1) | AU603375B2 (es) |
| BE (1) | BE1003959A5 (es) |
| CA (1) | CA1302888C (es) |
| CH (1) | CH672069A5 (es) |
| DE (1) | DE3728499A1 (es) |
| DK (1) | DK171392B1 (es) |
| FI (1) | FI873727A (es) |
| FR (1) | FR2605222B1 (es) |
| GB (1) | GB2195532B (es) |
| HK (1) | HK64993A (es) |
| IE (1) | IE60601B1 (es) |
| IT (1) | IT1211477B (es) |
| LU (1) | LU86973A1 (es) |
| NL (1) | NL8701994A (es) |
| NO (1) | NO873571L (es) |
| NZ (1) | NZ221564A (es) |
| SE (1) | SE502323C2 (es) |
| SG (1) | SG52393G (es) |
| ZA (1) | ZA876401B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
| US6329349B1 (en) * | 1997-10-23 | 2001-12-11 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents |
| AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| CN107773545A (zh) * | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| WO1986006960A2 (en) * | 1985-05-22 | 1986-12-04 | Beecham Group P.L.C. | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
| US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
| WO1987005508A1 (en) * | 1986-03-14 | 1987-09-24 | Medical College Of Wisconsin Research Foundation, | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| LU86973A1 (fr) | 1987-12-16 |
| GB8720219D0 (en) | 1987-10-07 |
| NZ221564A (en) | 1999-08-30 |
| KR950002151B1 (ko) | 1995-03-14 |
| SE8703308L (sv) | 1988-02-28 |
| ZA876401B (en) | 1988-04-27 |
| NL8701994A (nl) | 1988-03-16 |
| BE1003959A5 (fr) | 1992-07-22 |
| FI873727A (fi) | 1988-02-28 |
| US4870090A (en) | 1989-09-26 |
| KR880002525A (ko) | 1988-05-09 |
| SE502323C2 (sv) | 1995-10-02 |
| GB2195532A (en) | 1988-04-13 |
| AU7731187A (en) | 1988-03-03 |
| DE3728499A1 (de) | 1988-03-03 |
| CH672069A5 (es) | 1989-10-31 |
| NO873571L (no) | 1988-02-29 |
| JPS63152317A (ja) | 1988-06-24 |
| NO873571D0 (no) | 1987-08-24 |
| FR2605222A1 (fr) | 1988-04-22 |
| GB2195532B (en) | 1990-05-23 |
| DK441987A (da) | 1988-02-28 |
| HK64993A (en) | 1993-07-16 |
| SE8703308D0 (sv) | 1987-08-26 |
| IT1211477B (it) | 1989-11-03 |
| IT8767725A0 (it) | 1987-08-21 |
| FI873727A0 (fi) | 1987-08-27 |
| IE60601B1 (en) | 1994-07-27 |
| DK441987D0 (da) | 1987-08-25 |
| SG52393G (en) | 1993-08-06 |
| IE872218L (en) | 1988-02-27 |
| FR2605222B1 (fr) | 1991-02-22 |
| AU603375B2 (en) | 1990-11-15 |
| CA1302888C (en) | 1992-06-09 |
| JPH07121863B2 (ja) | 1995-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| VAN WOERT et al. | Therapy of intention myoclonus with L‐5‐hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486 | |
| AU2011316225B2 (en) | Combinations of serotonin receptor agonists for treatment of movement disorders | |
| TW201305B (es) | ||
| EP0658110B1 (en) | Use of norastemizole for the treatment of allergic rhinitis | |
| JPH11501282A (ja) | コリン受容体作用薬及び拮抗薬としてのエピバチジン及びその誘導体 | |
| US20140271890A1 (en) | Controlled-release pharmaceutical composition | |
| WO1997021439A1 (fr) | Medicament destine au traitement des troubles obsessifs compulsifs, de l'apnee du sommeil, des dysfonctions sexuelles, de l'emese et du mal des transports | |
| EP2714040A1 (en) | Combinations of serotonin receptor agonists for treatment of movement disorders | |
| DK171392B1 (da) | Anvendelse af N-(2-hydroxyethyl)nicotinamidnitrat eller et farmaceutisk acceptabelt salt deraf til fremstilling af et farmaceutisk præparat til forøgelse af hjernens glucoseoptagelse | |
| CA2433409C (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| US4088778A (en) | Method for the treatment of hypertension | |
| TWI657825B (zh) | 治療心血管疾病的組合藥物及其製備和使用方法 | |
| JPH02193922A (ja) | 細胞保護用組成物 | |
| JPS6081127A (ja) | 食欲抑制剤 | |
| RU2354378C1 (ru) | Комбинированный противотуберкулезный препарат | |
| KR100372906B1 (ko) | 뇌의 아세틸콜린 방출 증진제 | |
| JPWO2003068263A1 (ja) | 高血圧症治療薬 | |
| CN111374980A (zh) | 吡嗪酰胺、氟马西尼联合用于制备抗惊厥药物的应用 | |
| JPH0249725A (ja) | 脳代謝賦活剤 | |
| JPH01249754A (ja) | ニコチン酸リチウム塩半水化物ならびにアルコール中毒症の予防及び治療用のそれをベースとする製剤 | |
| CA2655019C (fr) | Utilisation d'un inhibiteur de vasopeptidase pour le traitement de l'hypertension arterielle pulmonaire | |
| Kamath | Study of Anticonvulsant effect of Simvastatin in Maximal Electroshock and Pentylenetetrazole Induced Seizure Model In Albino Mice | |
| EP0279787A1 (en) | Pharmaceutical compositions with synergistic antisecretory action for the healing of gastroduodenal ulcer | |
| WO2002051416A1 (fr) | Medicaments ameliorant les comportements de la vie courante chez des personnes atteintes de la maladie d'alzheimer | |
| JPH03200725A (ja) | 胃酸分泌抑制剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |
Country of ref document: DK |